Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
CNY 11.78
(0.68%)
CNY 11.78
(0.68%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -76.06 Million CNY | 38.75% |
| 2022 | -124.2 Million CNY | -314.21% |
| 2021 | -29.98 Million CNY | -175.39% |
| 2020 | 39.77 Million CNY | 18.2% |
| 2019 | 33.64 Million CNY | 290.45% |
| 2018 | 8.61 Million CNY | 122.69% |
| 2017 | -37.98 Million CNY | -366.82% |
| 2016 | 14.23 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -13.6 Million CNY | 68.8% |
| 2024 Q2 | -31.82 Million CNY | -133.91% |
| 2024 Q3 | -15.5 Million CNY | 51.28% |
| 2023 Q2 | -10.08 Million CNY | -2174.61% |
| 2023 FY | -76.06 Million CNY | 38.75% |
| 2023 Q4 | -43.61 Million CNY | -90.79% |
| 2023 Q3 | -22.85 Million CNY | -126.63% |
| 2023 Q1 | 486.16 Thousand CNY | 101.03% |
| 2022 Q3 | -8.8 Million CNY | 80.82% |
| 2022 FY | -124.2 Million CNY | -314.21% |
| 2022 Q2 | -45.88 Million CNY | -105.75% |
| 2022 Q1 | -22.3 Million CNY | 39.11% |
| 2022 Q4 | -47.21 Million CNY | -436.48% |
| 2021 Q2 | 1.53 Million CNY | -86.47% |
| 2021 Q1 | 11.32 Million CNY | 11.27% |
| 2021 Q4 | -36.62 Million CNY | -488.81% |
| 2021 Q3 | -6.22 Million CNY | -505.92% |
| 2021 FY | -29.98 Million CNY | -175.39% |
| 2020 Q2 | 21.54 Million CNY | 630.82% |
| 2020 Q1 | 2.94 Million CNY | -86.42% |
| 2020 FY | 39.77 Million CNY | 18.2% |
| 2020 Q4 | 10.18 Million CNY | 99.71% |
| 2020 Q3 | 5.09 Million CNY | -76.34% |
| 2019 Q4 | 21.7 Million CNY | 634.69% |
| 2019 Q2 | 9.97 Million CNY | 65.28% |
| 2019 Q1 | 6.03 Million CNY | 0.0% |
| 2019 FY | 33.64 Million CNY | 290.45% |
| 2019 Q3 | -4.05 Million CNY | -140.7% |
| 2018 FY | 8.61 Million CNY | 122.69% |
| 2017 FY | -37.98 Million CNY | -366.82% |
| 2016 FY | 14.23 Million CNY | 0.0% |